189 related articles for article (PubMed ID: 3489807)
41. Peritoneal adherent cell inhibit the generation of cytotoxic T lymphocytes with prostaglandin-mediated system.
Koga Y; Taniguchi K; Kubo C; Nomoto K
Cell Immunol; 1982 Jan; 66(1):195-201. PubMed ID: 6211243
[No Abstract] [Full Text] [Related]
42. Release of prostaglandin E2 from cells by photodynamic treatment in vitro.
Henderson BW; Donovan JM
Cancer Res; 1989 Dec; 49(24 Pt 1):6896-900. PubMed ID: 2531034
[TBL] [Abstract][Full Text] [Related]
43. Suppression of delayed-type hypersensitivity mediated by macrophage-like cells in mice with experimental liver injury.
Tajima S; Nishimura N; Ito K
Immunology; 1985 Jan; 54(1):57-64. PubMed ID: 2982732
[TBL] [Abstract][Full Text] [Related]
44. Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophages.
Bachwich PR; Chensue SW; Larrick JW; Kunkel SL
Biochem Biophys Res Commun; 1986 Apr; 136(1):94-101. PubMed ID: 3486658
[TBL] [Abstract][Full Text] [Related]
45. Two signals are required for accessory cells to induce B cell unresponsiveness. Tolerogenic Ig and prostaglandin.
Schad VC; Phipps RP
J Immunol; 1988 Jul; 141(1):79-84. PubMed ID: 2454266
[TBL] [Abstract][Full Text] [Related]
46. African trypanosomiasis alters prostaglandin production by murine peritoneal macrophages.
Fierer J; Salmon JA; Askonas BA
Clin Exp Immunol; 1984 Dec; 58(3):548-56. PubMed ID: 6391763
[TBL] [Abstract][Full Text] [Related]
47. Prostaglandin E2 inhibits the activation of cloned T cell hybridomas.
Makoul GT; Robinson DR; Bhalla AK; Glimcher LH
J Immunol; 1985 Apr; 134(4):2645-50. PubMed ID: 2857750
[TBL] [Abstract][Full Text] [Related]
48. Prostaglandin-mediated suppression of macrophage phagocytosis of Listeria monocytogenes.
Hutchison DL; Myers RL
Cell Immunol; 1987 Nov; 110(1):68-76. PubMed ID: 3119229
[TBL] [Abstract][Full Text] [Related]
49. Prostaglandin E production by Lewis lung carcinoma: mechanism for tumor establishment in vivo.
Young MR; Knies S
J Natl Cancer Inst; 1984 Apr; 72(4):919-22. PubMed ID: 6584667
[TBL] [Abstract][Full Text] [Related]
50. Influence of prostaglandin E2 and indomethacin on interferon-gamma production by cultured peripheral blood leukocytes of multiple sclerosis patients and healthy donors.
Vervliet G; Deckmyn H; Carton H; Billiau A
J Clin Immunol; 1985 Mar; 5(2):102-8. PubMed ID: 3921560
[TBL] [Abstract][Full Text] [Related]
51. Chronic infection due to Mycobacterium intracellulare in mice: association with macrophage release of prostaglandin E2 and reversal by injection of indomethacin, muramyl dipeptide, or interferon-gamma.
Edwards CK; Hedegaard HB; Zlotnik A; Gangadharam PR; Johnston RB; Pabst MJ
J Immunol; 1986 Mar; 136(5):1820-7. PubMed ID: 3005400
[TBL] [Abstract][Full Text] [Related]
52. Cytostatic and cytolytic activities of macrophages regulation by prostaglandins.
Mochizuki M; Zigler JS; Russell P; Gery I
Cell Immunol; 1984 Jan; 83(1):34-42. PubMed ID: 6581870
[TBL] [Abstract][Full Text] [Related]
53. Activation of natural killer-derived cytotoxic T lymphocytes. I. Regulation by macrophage and prostaglandins.
Ting CC; Hargrove ME
J Immunol; 1983 Oct; 131(4):1734-41. PubMed ID: 6604751
[TBL] [Abstract][Full Text] [Related]
54. The macrophage adherence phenomenon: its relationship to prostaglandin E2 and superoxide anion production and changes in transmembrane potential.
Kunkel SL; Duque RE
Prostaglandins; 1983 Dec; 26(6):893-904. PubMed ID: 6098933
[TBL] [Abstract][Full Text] [Related]
55. Effect of chlorambucil and indomethacin on growth and prostaglandin levels in sensitive and resistant Walker carcinoma.
Tisdale MJ; Gibbs J; Dobrzanski RJ
Chem Biol Interact; 1982 Mar; 39(2):221-30. PubMed ID: 6949655
[TBL] [Abstract][Full Text] [Related]
56. Lack of prostaglandin E2-mediated monocyte suppressive activity in newborn and mothers.
Fischer A; Durandy A; Mamas S; McCall E; Dray F; Griscelli C
Clin Exp Immunol; 1982 Aug; 49(2):377-85. PubMed ID: 6215198
[TBL] [Abstract][Full Text] [Related]
57. Macrophage activation by granulocyte/macrophage colony-stimulating factor. Priming for enhanced release of tumor necrosis factor-alpha and prostaglandin E2.
Heidenreich S; Gong JH; Schmidt A; Nain M; Gemsa D
J Immunol; 1989 Aug; 143(4):1198-205. PubMed ID: 2473121
[TBL] [Abstract][Full Text] [Related]
58. Regulation of human immunoglobulin production in vitro by prostaglandin E2.
Staite ND; Panayi GS
Clin Exp Immunol; 1982 Jul; 49(1):115-22. PubMed ID: 6957277
[TBL] [Abstract][Full Text] [Related]
59. Macrophage-mediated tumor cell killing: regulation of expression of cytolytic activity by prostaglandin E.
Taffet SM; Russell SW
J Immunol; 1981 Feb; 126(2):424-7. PubMed ID: 7451984
[TBL] [Abstract][Full Text] [Related]
60. Polychlorinated biphenyl-induced suppression of cytotoxic T lymphocyte activity: role of prostaglandin-E2.
De Krey GK; Baecher-Steppan L; Fowles JR; Kerkvliet NI
Toxicol Lett; 1994 Dec; 74(3):211-20. PubMed ID: 7871545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
